The only constant in life is change: Summary of the last 4 years of Advances in Clinical and Experimental Medicine.

Abstract

In the last 4 years, the journal Advances in Clinical and Experimental Medicine has made significant strides in adapting to changes in scientific publishing. It has maintained high levels of citations and submitted manuscripts, publishing a considerable number of articles ahead of print releases to minimize wait times. With a solid reputation and a growing base of over 7,000 reviewers, the journal upholds rigorous ethical standards and thorough statistical verification for all manuscripts. Bibliometric indicators showcase the impact of Adv Clin Exp Med, including an increased impact factor, CiteScore, Index Copernicus Value (ICV) and recognition in indexes and bases like Scopus and PubMed Central (PMC). International cooperation support for early-career researchers are key focuses, with efforts to provide guidelines, online meetings, and social media promotion. Various materials for authors prepared by the editorial staff are discussed, including detailed instructions for authors, tips regarding graphical abstracts and choosing a checklist, as well as ethical guidelines, a brochure on the rules of statistical analysis and data presentation, and technical requirements for figures. The journal also emphasizes data sharing, detailed procedures for errata and retractions, and clear policies concerning the use of artificial intelligence (AI) tools. Calls for submissions show authors the optimal direction for creating original, innovative scientific papers. Financing from the Polish Ministry of Science and Higher Education ensures the financial stability of the journal. By adapting to the evolving landscape of scientific communication, Adv Clin Exp Med remains dedicated to facilitating open access publishing and disseminating high-quality medical research to its readers.